BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 2:47:00 PM | Browse: 872 | Download: 897
Publication Name World Journal of Cardiology
Manuscript ID 8076
Country Türkiye
Received
2013-12-15 16:06
Peer-Review Started
2013-12-16 09:10
To Make the First Decision
2014-02-13 15:57
Return for Revision
2014-02-17 18:49
Revised
Second Decision
2014-05-14 16:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-14 16:46
Articles in Press
2014-05-23 09:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-17 13:44
Publish the Manuscript Online
2014-08-20 20:27
ISSN 1949-8462 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Risks and diagnosis of coronary artery disease in Hodgkin lymphoma survivors
Manuscript Source Invited Manuscript
All Author List Serhan Kupeli
Funding Agency and Grant Number
Corresponding Author Serhan Kupeli, MD, MSc, Associate Professor of Pediatrics, Department of Pediatric Oncology and Pediatric Bone Marrow Transplantation Unit, Faculty of Medicine, ?ukurova University, Rekt?rlü?ü, 01330 Adana, Turkey. serhankupeli@cu.edu.tr
Key Words Coronary artery disease; Hodgkin lymphoma; Computed tomography angiography; Cardiotoxicity; Survivors
Core Tip With substantial increase in survival rates from cancer, late adverse effects of cancer therapy have become extremely important. Mediastinal radiotherapy and cardiotoxic chemotherapeutic agents are routinely used to treat Hodgkin lymphoma (HL) but are commonly associated with a variety of cardiovascular complications including coronary artery disease (CAD). For surviving individuals after HL treatment, coronary computed tomography angiography is a non-invasive and useful method in detecting CAD at an early stage. Survivors of HL especially treated with combined chemoradiotherapy at young ages, who carry the risk of CAD development are candidates for coronary computed tomography angiography.
Publish Date 2014-08-20 20:27
Citation Kupeli S. Risks and diagnosis of coronary artery disease in Hodgkin lymphoma survivors. World J Cardiol 2014; 6(7): 555-561
URL http://www.wjgnet.com/1949-8462/full/v6/i7/555.htm
DOI http://dx.doi.org/10.4330/wjc.v6.i7.555
Full Article (PDF) WJC-6-555.pdf
Full Article (Word) WJC-6-555.doc
Manuscript File 8076-Review.docx
Answering Reviewers 8076-Answering reviewers.pdf
Copyright License Agreement 8076-Copyright assignment.pdf
Peer-review Report 8076-Peer review(s).pdf
Scientific Editor Work List 8076-Scientific editor work list.pdf